Replies to post #7392 on Momenta Pharmaceuticals, Inc. (MNTA)

[rwwine]

Mine are:

2011 + $4.02
2012 + $1.72
2013 + $1.58

Assumptions
- No other gL enters the market place for 2012 & 2013.
- No $ contribution from other products (mC, FOB, etc...)
- Loss of market share to oral anticoagulant drugs is factored in to 2012 & 2013.
- MNTA's NOL's will largely get used up in 2011. MNTA will be fully taxed in 2012 and going forward......

Based on my interpretation of the agreement between MNTA/NVS apropos the "hybrid" royalty/profit share arrangement.